Development of a new enterprise "Ambulatory for group practice for primary dental care - Prevadent"

The new company “Ambulatory for group practice for primary dental care – Prevadent” Ltd (for short Prevadent) was established in the city of Montana and this project will lead to the development of the company’s dental services in a high quality. They will be focused on effective prevention, diagnosis and individual therapy of patients in this area. The activity falls entirely within the scope of the priority areas of ISIS "Personal Medicine, Diagnostics and Individual Therapy, Medicinal and Pharmaceutical forms and Agents " in the thematic area "Healthy Living and Bio-Technology Industry".
The main objective of the project is to be achieved a market realization and entrepreneurial idea development of high-quality dental services in the sector Q86 "Human health", according to NACE-2008, related to overcoming the European and regional challenges. It will be realized through activities for implementation in the market of the entrepreneurial idea and through the project visualization. Within the first activity 3 persons - a qualified personnel will be hired, incl. and a person with a permanent disability, also a sustainable employment will be subsequently provided for 6 months period minimum after the project. In addition, fixed assets will be purchased - operating dental microscope - 1 pc, dental chair set - 1 pc, periphery - 1 pc; intraoral X-ray – 1 pc; Phosphor plate scanning device - 1pc, panoramic digital X-ray - 1pc.
As a result of the project will be created and developed a sustainable new enterprise in sector Q86 "Human health" with successful market realization and application of dental services, sustainable employment of 3 persons, incl. a person with a permanent disability, also an ecological and social effect will be reached.

Comments
Leave a comment

Overview

Status Closed (completion date)
Start date 07 Aug, 2019
End date 07 Feb, 2021
Contract date 07 Aug, 2019
View in UMIS

Financial information

Total cost 249,297.96
Grant 199,438.37
Self finance 49,859.59
Total paid 157,450.98
EU participation percent 85.0%

Location